1. Survival and cell cycle progression delay of human lymphoma cells in vitro exposed to VP 16–213;Drewinko;Cancer Treat Rep,1976
2. In vitro cytotoxicity of VP16 on primary tumour and metastasis of Lewis lung carcinoma;D'Incalci;Em J Cancer,1982
3. Time-schedule dependency of the inhibiting activity of various anticancer drugs in the clonogenic assay;Matsushima;Cancer Chemother Pharmacol,1985
4. The effect of the two epipodophyllotoxin derivatives etoposide (VP16) and teniposide (VM26) on cell lines established from patients with small cell carcinoma of the lung;Roed;Cancer Chemother Pharmacol,1987
5. In vitro pharmacodynamic evaluation of VP 16–213 and implications for chemotherapy;Wolff;Cancer Chemother Pharmacol,1987